Raymond M. Jordt serves as Executive at Altimmune, Inc., where they oversee executive responsibilities. Since joining the company, Raymond M. Jordt has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 27, 2026 involved exercising options for 15,850 shares valued at $0.
Raymond M. Jordt currently holds 47,550 shares of Altimmune, Inc. (ALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raymond M. Jordt has been a net neutral trader of ALT stock. They have purchased $0 and sold $0 worth of shares.
Raymond M. Jordt's most recent insider trade was on Jan 27, 2026, when they sold 15,850 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.18 |
| Discretionary |
| Jan 27, 2026 | ALT | $0 | Option Exercise | 15,850 | $N/A | Discretionary |
| Jan 25, 2026 | ALT | $0 | Option Exercise | 14,600 | $N/A | Discretionary |
| Jan 25, 2026 | ALT | $21.2K | Payment | 3,855 | $5.50 | Discretionary |
| Jan 25, 2026 | ALT | $0 | Option Exercise | 14,600 | $N/A | Discretionary |
| Jul 31, 2025 | ALT | $4.3K | Award | 1,368 | $3.14 | Discretionary |
| Jul 31, 2024 | ALT | $5.0K | Award | 917 | $5.41 | Discretionary |
| Jan 31, 2024 | ALT | $13.5K | Award | 5,030 | $2.69 | Discretionary |
| Jan 1, 2024 | ALT | $28.2K | Payment | 2,503 | $11.25 | Discretionary |
| Jan 1, 2024 | ALT | $0 | Option Exercise | 9,375 | $N/A | Discretionary |
| Jul 31, 2023 | ALT | $5.1K | Award | 1,832 | $2.81 | Discretionary |